MAP2K7 and cancer: MEK is a key component of the mitogen-activated protein kinase (MAPK) signalling pathway, which is integral to the proliferation and survival of cancer cells.7 Activation of the GTPase RAS leads to a phosphorylation cascade via the kinases RAF, MEK and ERK that results in the activation of oncogenic gene expression.